Antisense Oligonucleotides Targeting Y-Box Binding Protein-1 Inhibit Tumor Angiogenesis by Downregulating Bcl-xL-VEGFR2/-Tie Axes
Y-box binding protein-1 (YB-1), involved in cancer progression and chemoradiation resistance, is overexpressed in not only cancer cells but also tumor blood vessels. In this study, we investigated the potential value of amido-bridged nucleic acid (AmNA)-modified antisense oligonucleotides (ASOs) tar...
Saved in:
Main Authors: | Kiyoko Setoguchi (Author), Lin Cui (Author), Nobutaka Hachisuka (Author), Sumalee Obchoei (Author), Kentaro Shinkai (Author), Fuminori Hyodo (Author), Kiyoko Kato (Author), Fumito Wada (Author), Tsuyoshi Yamamoto (Author), Mariko Harada-Shiba (Author), Satoshi Obika (Author), Kenji Nakano (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Highly Potent GalNAc-Conjugated Tiny LNA Anti-miRNA-122 Antisense Oligonucleotides
by: Tsuyoshi Yamamoto, et al.
Published: (2021) -
Drug discovery and development scheme for liver-targeting bridged nucleic acid antisense oligonucleotides
by: Fumito Wada, et al.
Published: (2021) -
Cholesterol-lowering Action of BNA-based Antisense Oligonucleotides Targeting PCSK9 in Atherogenic Diet-induced Hypercholesterolemic Mice
by: Tsuyoshi Yamamoto, et al.
Published: (2012) -
Base-modified aptamers obtained by cell-internalization SELEX facilitate cellular uptake of an antisense oligonucleotide
by: Keisuke Tanaka, et al.
Published: (2021) -
Tissue pharmacokinetics of antisense oligonucleotides
by: Erica Bäckström, et al.
Published: (2024)